Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Leukemia, Hairy Cell | 3 | 2017 | 82 | 1.490 |
Why?
|
Lymphoma, T-Cell | 6 | 2024 | 303 | 1.200 |
Why?
|
Myeloproliferative Disorders | 7 | 2023 | 614 | 1.030 |
Why?
|
Leukemia, Myeloid, Acute | 15 | 2023 | 3620 | 1.020 |
Why?
|
Integrin alpha Chains | 2 | 2014 | 93 | 0.870 |
Why?
|
Myelodysplastic Syndromes | 7 | 2023 | 1399 | 0.850 |
Why?
|
Plasmacytoma | 1 | 2019 | 170 | 0.620 |
Why?
|
Skin Neoplasms | 9 | 2023 | 5857 | 0.610 |
Why?
|
Proto-Oncogene Proteins c-kit | 2 | 2020 | 725 | 0.590 |
Why?
|
Dendritic Cells | 6 | 2023 | 2749 | 0.580 |
Why?
|
Mastocytosis | 1 | 2020 | 150 | 0.580 |
Why?
|
Hematologic Neoplasms | 4 | 2023 | 1906 | 0.510 |
Why?
|
Enteropathy-Associated T-Cell Lymphoma | 1 | 2014 | 13 | 0.480 |
Why?
|
MAP Kinase Kinase 1 | 1 | 2016 | 331 | 0.470 |
Why?
|
Leukemia, T-Cell | 1 | 2014 | 101 | 0.470 |
Why?
|
Lymphoma, B-Cell | 3 | 2019 | 945 | 0.460 |
Why?
|
Integrin beta3 | 2 | 2016 | 120 | 0.450 |
Why?
|
Neoplasms, Radiation-Induced | 2 | 2019 | 555 | 0.420 |
Why?
|
Antigens, CD | 2 | 2014 | 4031 | 0.420 |
Why?
|
Lymph Nodes | 5 | 2023 | 3471 | 0.410 |
Why?
|
Lymphoma, Mantle-Cell | 3 | 2023 | 238 | 0.410 |
Why?
|
Immunophenotyping | 8 | 2019 | 1866 | 0.400 |
Why?
|
Paired Box Transcription Factors | 1 | 2012 | 206 | 0.390 |
Why?
|
Lymphoma, Large-Cell, Anaplastic | 3 | 2019 | 168 | 0.390 |
Why?
|
Hemangiosarcoma | 2 | 2019 | 216 | 0.380 |
Why?
|
Lymphoma | 5 | 2022 | 1907 | 0.370 |
Why?
|
Micrococcaceae | 1 | 2010 | 8 | 0.360 |
Why?
|
Immunoenzyme Techniques | 1 | 2013 | 1705 | 0.340 |
Why?
|
Bone Resorption | 4 | 2010 | 727 | 0.330 |
Why?
|
Sarcoma, Myeloid | 2 | 2023 | 52 | 0.330 |
Why?
|
Neoplasms, Second Primary | 2 | 2017 | 1060 | 0.310 |
Why?
|
Bone Marrow | 7 | 2023 | 2929 | 0.300 |
Why?
|
Dermatitis | 1 | 2010 | 203 | 0.300 |
Why?
|
Lymphoma, T-Cell, Cutaneous | 2 | 2020 | 210 | 0.290 |
Why?
|
Langerhans Cells | 2 | 2018 | 169 | 0.290 |
Why?
|
Mutation | 18 | 2023 | 30230 | 0.280 |
Why?
|
Hemostasis | 1 | 2009 | 468 | 0.280 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2014 | 959 | 0.270 |
Why?
|
Mutation, Missense | 1 | 2016 | 2593 | 0.270 |
Why?
|
Lymphohistiocytosis, Hemophagocytic | 2 | 2020 | 271 | 0.270 |
Why?
|
Lymphoproliferative Disorders | 3 | 2020 | 529 | 0.260 |
Why?
|
Lymphoma, Extranodal NK-T-Cell | 2 | 2018 | 48 | 0.260 |
Why?
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 3 | 2020 | 384 | 0.260 |
Why?
|
Receptors, Immunologic | 2 | 2024 | 1416 | 0.250 |
Why?
|
Translocation, Genetic | 3 | 2021 | 1395 | 0.250 |
Why?
|
Cell Transformation, Neoplastic | 3 | 2023 | 2846 | 0.240 |
Why?
|
Receptors, CXCR4 | 5 | 2020 | 729 | 0.240 |
Why?
|
Histiocytosis, Langerhans-Cell | 2 | 2017 | 171 | 0.240 |
Why?
|
Immunohistochemistry | 13 | 2020 | 11117 | 0.230 |
Why?
|
High-Throughput Nucleotide Sequencing | 5 | 2021 | 3666 | 0.230 |
Why?
|
Lymphoma, Follicular | 2 | 2021 | 460 | 0.230 |
Why?
|
Antibodies, Monoclonal | 7 | 2024 | 9261 | 0.230 |
Why?
|
Genes, Mating Type, Fungal | 2 | 2002 | 25 | 0.220 |
Why?
|
Waldenstrom Macroglobulinemia | 3 | 2020 | 1077 | 0.210 |
Why?
|
Bacteremia | 1 | 2010 | 985 | 0.210 |
Why?
|
Breast Implants | 2 | 2018 | 414 | 0.210 |
Why?
|
Paraffin Embedding | 2 | 2014 | 306 | 0.210 |
Why?
|
Core Binding Factors | 2 | 2021 | 29 | 0.200 |
Why?
|
Genes, Fungal | 2 | 2002 | 439 | 0.190 |
Why?
|
Skin | 4 | 2023 | 4499 | 0.190 |
Why?
|
Hodgkin Disease | 3 | 2018 | 1386 | 0.190 |
Why?
|
Xenograft Model Antitumor Assays | 6 | 2024 | 3616 | 0.190 |
Why?
|
Dog Diseases | 1 | 2022 | 143 | 0.190 |
Why?
|
Nuclear Proteins | 6 | 2023 | 5802 | 0.180 |
Why?
|
Lectins, C-Type | 1 | 2024 | 591 | 0.180 |
Why?
|
Core Binding Factor beta Subunit | 1 | 2020 | 42 | 0.180 |
Why?
|
Rwanda | 2 | 2021 | 669 | 0.180 |
Why?
|
Tumor Suppressor Protein p53 | 4 | 2019 | 2950 | 0.170 |
Why?
|
Humans | 77 | 2024 | 768298 | 0.170 |
Why?
|
Cyclophosphamide | 3 | 2022 | 2226 | 0.170 |
Why?
|
Wills | 1 | 2019 | 13 | 0.160 |
Why?
|
Carcinoma, Merkel Cell | 1 | 2023 | 330 | 0.160 |
Why?
|
Hematopoietic Stem Cell Transplantation | 5 | 2023 | 5711 | 0.160 |
Why?
|
Cyclin D1 | 2 | 2019 | 453 | 0.160 |
Why?
|
Colic | 1 | 2019 | 44 | 0.160 |
Why?
|
Ribonucleoproteins | 1 | 2021 | 359 | 0.160 |
Why?
|
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2018 | 230 | 0.160 |
Why?
|
Blood Platelets | 1 | 2009 | 2476 | 0.160 |
Why?
|
Pancytopenia | 1 | 2019 | 102 | 0.160 |
Why?
|
Alkylating Agents | 1 | 2019 | 132 | 0.160 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 2 | 2018 | 362 | 0.150 |
Why?
|
Leukemic Infiltration | 1 | 2018 | 47 | 0.150 |
Why?
|
Fungal Proteins | 1 | 2002 | 906 | 0.150 |
Why?
|
Histiocytes | 1 | 2018 | 97 | 0.150 |
Why?
|
Macrophages | 4 | 2019 | 5796 | 0.150 |
Why?
|
Chromosomes, Human, Pair 21 | 1 | 2018 | 229 | 0.150 |
Why?
|
Schistosomiasis mansoni | 1 | 2018 | 94 | 0.150 |
Why?
|
Ultraviolet Rays | 1 | 2023 | 1100 | 0.150 |
Why?
|
Blood Cells | 1 | 2019 | 308 | 0.150 |
Why?
|
Schistosoma mansoni | 1 | 2018 | 156 | 0.150 |
Why?
|
Leukemia, Myelomonocytic, Chronic | 1 | 2018 | 93 | 0.140 |
Why?
|
Precursor Cells, T-Lymphoid | 1 | 2017 | 19 | 0.140 |
Why?
|
Prognosis | 10 | 2023 | 30020 | 0.140 |
Why?
|
Aged, 80 and over | 18 | 2021 | 59683 | 0.140 |
Why?
|
Bone Neoplasms | 5 | 2015 | 2565 | 0.140 |
Why?
|
Chromosomes, Human, Pair 8 | 1 | 2018 | 453 | 0.140 |
Why?
|
Antigens, Differentiation | 1 | 2019 | 921 | 0.130 |
Why?
|
GATA3 Transcription Factor | 1 | 2017 | 163 | 0.130 |
Why?
|
Middle Aged | 31 | 2021 | 223463 | 0.130 |
Why?
|
Histone Demethylases | 1 | 2019 | 322 | 0.130 |
Why?
|
Receptors, IgG | 1 | 2019 | 564 | 0.130 |
Why?
|
Hematopoiesis, Extramedullary | 1 | 2016 | 53 | 0.130 |
Why?
|
Saccharomyces cerevisiae Proteins | 2 | 2002 | 1839 | 0.130 |
Why?
|
Adenosine Triphosphate | 1 | 2002 | 2003 | 0.130 |
Why?
|
Histiocytosis, Sinus | 1 | 2016 | 44 | 0.130 |
Why?
|
Histiocytic Necrotizing Lymphadenitis | 1 | 2016 | 27 | 0.130 |
Why?
|
Herpesvirus 4, Human | 1 | 2021 | 1082 | 0.130 |
Why?
|
Male | 40 | 2021 | 364870 | 0.130 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2021 | 731 | 0.130 |
Why?
|
Genetic Testing | 3 | 2019 | 3587 | 0.130 |
Why?
|
Aged | 29 | 2021 | 171544 | 0.120 |
Why?
|
Tissue Banks | 1 | 2016 | 184 | 0.120 |
Why?
|
Breast Implantation | 1 | 2018 | 224 | 0.120 |
Why?
|
Gene Expression Regulation, Neoplastic | 4 | 2019 | 8628 | 0.120 |
Why?
|
DNA Repair | 2 | 2021 | 2050 | 0.120 |
Why?
|
Calreticulin | 1 | 2016 | 115 | 0.120 |
Why?
|
Cardiac Tamponade | 1 | 2016 | 175 | 0.120 |
Why?
|
Immunoglobulin M | 2 | 2017 | 1528 | 0.120 |
Why?
|
Female | 39 | 2023 | 397050 | 0.120 |
Why?
|
Breast Neoplasms | 6 | 2019 | 21163 | 0.120 |
Why?
|
Receptors, Thrombopoietin | 1 | 2016 | 160 | 0.120 |
Why?
|
Saccharomyces cerevisiae | 2 | 2002 | 2678 | 0.120 |
Why?
|
Quinazolinones | 1 | 2016 | 219 | 0.120 |
Why?
|
B-Lymphocytes | 3 | 2017 | 4785 | 0.120 |
Why?
|
Primary Myelofibrosis | 1 | 2016 | 209 | 0.110 |
Why?
|
Frozen Sections | 1 | 2014 | 154 | 0.110 |
Why?
|
Killer Cells, Natural | 2 | 2024 | 2207 | 0.110 |
Why?
|
Pathology, Clinical | 1 | 2017 | 376 | 0.110 |
Why?
|
Activated Protein C Resistance | 1 | 2013 | 18 | 0.110 |
Why?
|
DNA Mutational Analysis | 2 | 2020 | 4120 | 0.110 |
Why?
|
Review Literature as Topic | 1 | 2016 | 353 | 0.110 |
Why?
|
Myeloid Differentiation Factor 88 | 1 | 2018 | 582 | 0.110 |
Why?
|
HLA Antigens | 1 | 2019 | 1337 | 0.110 |
Why?
|
Colonic Polyps | 1 | 2019 | 557 | 0.110 |
Why?
|
Mice | 20 | 2024 | 82004 | 0.110 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2016 | 450 | 0.110 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 2 | 2016 | 1643 | 0.110 |
Why?
|
Peroneal Nerve | 1 | 2013 | 80 | 0.110 |
Why?
|
Leg | 1 | 2018 | 1088 | 0.110 |
Why?
|
Adult | 25 | 2023 | 223622 | 0.100 |
Why?
|
Factor V | 1 | 2013 | 168 | 0.100 |
Why?
|
Polyarteritis Nodosa | 1 | 2013 | 70 | 0.100 |
Why?
|
Multiple Myeloma | 3 | 2017 | 5192 | 0.100 |
Why?
|
Purines | 1 | 2016 | 615 | 0.100 |
Why?
|
Gene Deletion | 2 | 2019 | 2673 | 0.100 |
Why?
|
Cell Line, Tumor | 7 | 2024 | 17132 | 0.100 |
Why?
|
Lymphoma, T-Cell, Peripheral | 1 | 2014 | 125 | 0.100 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2020 | 1614 | 0.100 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 5 | 2022 | 11854 | 0.100 |
Why?
|
Cell Cycle Proteins | 2 | 2021 | 3457 | 0.100 |
Why?
|
Animals | 23 | 2024 | 169322 | 0.100 |
Why?
|
Organ Specificity | 2 | 2023 | 1966 | 0.100 |
Why?
|
Proto-Oncogene Proteins | 3 | 2020 | 4526 | 0.100 |
Why?
|
Clone Cells | 3 | 2023 | 1671 | 0.100 |
Why?
|
Pericardium | 1 | 2016 | 679 | 0.100 |
Why?
|
Lymphoma, B-Cell, Marginal Zone | 1 | 2013 | 180 | 0.090 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2020 | 1558 | 0.090 |
Why?
|
Leukemia | 2 | 2017 | 1526 | 0.090 |
Why?
|
Hematopoiesis | 2 | 2017 | 2058 | 0.090 |
Why?
|
Neoplastic Cells, Circulating | 1 | 2018 | 957 | 0.090 |
Why?
|
Melanoma | 1 | 2009 | 5705 | 0.090 |
Why?
|
Gait Disorders, Neurologic | 1 | 2013 | 243 | 0.090 |
Why?
|
Antineoplastic Agents | 6 | 2018 | 13696 | 0.090 |
Why?
|
Neoplasm Transplantation | 2 | 2016 | 2017 | 0.090 |
Why?
|
DNA-Binding Proteins | 4 | 2020 | 9618 | 0.090 |
Why?
|
Flow Cytometry | 2 | 2018 | 5898 | 0.090 |
Why?
|
Sarcoidosis | 1 | 2016 | 534 | 0.090 |
Why?
|
Actinomycetales Infections | 1 | 2010 | 30 | 0.090 |
Why?
|
Mice, Inbred NOD | 3 | 2021 | 1839 | 0.090 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2015 | 755 | 0.090 |
Why?
|
Gastrointestinal Diseases | 1 | 2019 | 1207 | 0.090 |
Why?
|
Receptor, Notch1 | 1 | 2013 | 520 | 0.090 |
Why?
|
Cell Differentiation | 2 | 2018 | 11659 | 0.090 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2016 | 1408 | 0.090 |
Why?
|
Hospitals | 1 | 2023 | 3905 | 0.080 |
Why?
|
Neoplasm Proteins | 2 | 2019 | 3609 | 0.080 |
Why?
|
Biopsy | 4 | 2018 | 6808 | 0.080 |
Why?
|
Prednisolone | 2 | 2022 | 327 | 0.080 |
Why?
|
Repressor Proteins | 2 | 2017 | 2986 | 0.080 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2017 | 1376 | 0.080 |
Why?
|
Mice, SCID | 3 | 2021 | 2632 | 0.080 |
Why?
|
Predictive Value of Tests | 5 | 2018 | 15455 | 0.080 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2014 | 620 | 0.080 |
Why?
|
Transcriptional Activation | 1 | 2015 | 1748 | 0.080 |
Why?
|
MAP Kinase Signaling System | 1 | 2016 | 1492 | 0.080 |
Why?
|
Survival Rate | 4 | 2019 | 12870 | 0.080 |
Why?
|
Medical Oncology | 1 | 2020 | 2348 | 0.080 |
Why?
|
Epigenesis, Genetic | 2 | 2019 | 3826 | 0.080 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2018 | 1428 | 0.070 |
Why?
|
Vincristine | 2 | 2022 | 1040 | 0.070 |
Why?
|
Hematopoietic Stem Cells | 2 | 2017 | 3407 | 0.070 |
Why?
|
Chemokine CXCL12 | 1 | 2010 | 457 | 0.070 |
Why?
|
Bone and Bones | 2 | 2017 | 2588 | 0.070 |
Why?
|
Mice, Mutant Strains | 2 | 2021 | 1755 | 0.070 |
Why?
|
Hepatitis B | 1 | 2013 | 707 | 0.070 |
Why?
|
Sarcoma | 1 | 2019 | 1806 | 0.070 |
Why?
|
Genomics | 2 | 2021 | 5916 | 0.070 |
Why?
|
Opportunistic Infections | 1 | 2010 | 375 | 0.070 |
Why?
|
Immune Tolerance | 1 | 2016 | 2324 | 0.070 |
Why?
|
Sulfonamides | 1 | 2016 | 1980 | 0.070 |
Why?
|
Drug Therapy | 1 | 2010 | 504 | 0.070 |
Why?
|
Dioxygenases | 2 | 2020 | 351 | 0.070 |
Why?
|
Rabbits | 1 | 2013 | 4782 | 0.070 |
Why?
|
Osteoclasts | 2 | 2007 | 711 | 0.070 |
Why?
|
Algorithms | 3 | 2017 | 14154 | 0.070 |
Why?
|
Crohn Disease | 1 | 2019 | 2293 | 0.060 |
Why?
|
Peptides | 1 | 2018 | 4352 | 0.060 |
Why?
|
Cell Lineage | 3 | 2023 | 2574 | 0.060 |
Why?
|
Diagnosis, Differential | 3 | 2020 | 13019 | 0.060 |
Why?
|
Apyrase | 1 | 2008 | 376 | 0.060 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 1 | 2012 | 936 | 0.060 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2012 | 1094 | 0.060 |
Why?
|
Alleles | 4 | 2019 | 6892 | 0.060 |
Why?
|
Combined Modality Therapy | 2 | 2017 | 8562 | 0.060 |
Why?
|
Retrospective Studies | 11 | 2023 | 81768 | 0.060 |
Why?
|
Immunocompromised Host | 1 | 2010 | 863 | 0.060 |
Why?
|
Treatment Outcome | 10 | 2022 | 65365 | 0.060 |
Why?
|
Genome, Human | 1 | 2017 | 4450 | 0.060 |
Why?
|
Gamma Rays | 2 | 2002 | 319 | 0.060 |
Why?
|
Tumor Burden | 2 | 2008 | 1913 | 0.060 |
Why?
|
Science | 1 | 2006 | 237 | 0.060 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2006 | 631 | 0.060 |
Why?
|
Mastectomy | 1 | 2012 | 1851 | 0.060 |
Why?
|
Cost-Benefit Analysis | 1 | 2017 | 5538 | 0.060 |
Why?
|
Dose-Response Relationship, Radiation | 2 | 2002 | 881 | 0.060 |
Why?
|
Meiosis | 2 | 2002 | 327 | 0.050 |
Why?
|
Recurrence | 3 | 2023 | 8501 | 0.050 |
Why?
|
Early Detection of Cancer | 1 | 2018 | 3236 | 0.050 |
Why?
|
DNA Damage | 3 | 2021 | 2459 | 0.050 |
Why?
|
Random Allocation | 2 | 2019 | 2397 | 0.050 |
Why?
|
Models, Biological | 2 | 2017 | 9494 | 0.050 |
Why?
|
Bone Diseases | 1 | 2006 | 417 | 0.050 |
Why?
|
Haploidy | 1 | 2002 | 127 | 0.050 |
Why?
|
Young Adult | 8 | 2021 | 60048 | 0.050 |
Why?
|
Genetic Predisposition to Disease | 3 | 2019 | 18047 | 0.050 |
Why?
|
Procarbazine | 1 | 2022 | 172 | 0.050 |
Why?
|
Rad51 Recombinase | 1 | 2002 | 191 | 0.050 |
Why?
|
Kaplan-Meier Estimate | 3 | 2019 | 6541 | 0.050 |
Why?
|
Hydrolysis | 1 | 2002 | 648 | 0.050 |
Why?
|
Transplantation, Heterologous | 1 | 2009 | 2394 | 0.050 |
Why?
|
Mentors | 1 | 2006 | 672 | 0.050 |
Why?
|
Child, Preschool | 6 | 2021 | 42654 | 0.050 |
Why?
|
Chromosome Aberrations | 2 | 2021 | 1780 | 0.040 |
Why?
|
Catalysis | 1 | 2002 | 769 | 0.040 |
Why?
|
U937 Cells | 1 | 2021 | 260 | 0.040 |
Why?
|
Endodeoxyribonucleases | 1 | 2001 | 166 | 0.040 |
Why?
|
DNA Repair Enzymes | 1 | 2002 | 346 | 0.040 |
Why?
|
Neoplasm Metastasis | 2 | 2008 | 4921 | 0.040 |
Why?
|
T-Lymphocytes | 1 | 2018 | 10266 | 0.040 |
Why?
|
Exodeoxyribonucleases | 1 | 2001 | 191 | 0.040 |
Why?
|
Plasmids | 2 | 2002 | 2267 | 0.040 |
Why?
|
Health Services Accessibility | 1 | 2017 | 5511 | 0.040 |
Why?
|
Molecular Biology | 1 | 2023 | 573 | 0.040 |
Why?
|
Remission Induction | 2 | 2018 | 2407 | 0.040 |
Why?
|
Child | 8 | 2021 | 80894 | 0.040 |
Why?
|
Radiotherapy | 1 | 2006 | 1509 | 0.040 |
Why?
|
Toll-Like Receptor 9 | 1 | 2020 | 199 | 0.040 |
Why?
|
Genotype | 3 | 2017 | 13038 | 0.040 |
Why?
|
Adolescent | 8 | 2021 | 89182 | 0.040 |
Why?
|
Survival Analysis | 3 | 2017 | 10117 | 0.040 |
Why?
|
Cell Division | 2 | 2007 | 4478 | 0.040 |
Why?
|
K562 Cells | 1 | 2021 | 637 | 0.040 |
Why?
|
Kidney | 1 | 2014 | 7063 | 0.040 |
Why?
|
Disease Models, Animal | 4 | 2021 | 18358 | 0.040 |
Why?
|
fms-Like Tyrosine Kinase 3 | 1 | 2022 | 494 | 0.040 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2019 | 9433 | 0.040 |
Why?
|
Imidazolines | 1 | 2018 | 18 | 0.040 |
Why?
|
Neoplasms | 2 | 2019 | 22389 | 0.040 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2019 | 224 | 0.040 |
Why?
|
Phthalazines | 1 | 2021 | 397 | 0.040 |
Why?
|
Skull Base | 1 | 2021 | 294 | 0.040 |
Why?
|
Digestive System | 1 | 2019 | 244 | 0.040 |
Why?
|
Bone Marrow Examination | 1 | 2018 | 154 | 0.040 |
Why?
|
Phenotype | 4 | 2017 | 16716 | 0.040 |
Why?
|
Cell Death | 1 | 2023 | 1681 | 0.040 |
Why?
|
Depsipeptides | 1 | 2018 | 96 | 0.040 |
Why?
|
Hemorrhage | 1 | 2009 | 3461 | 0.040 |
Why?
|
Genetic Association Studies | 2 | 2019 | 2741 | 0.040 |
Why?
|
Neoplasm Staging | 1 | 2012 | 11254 | 0.040 |
Why?
|
Hyperplasia | 1 | 2020 | 1152 | 0.040 |
Why?
|
Zygote | 1 | 2017 | 115 | 0.040 |
Why?
|
DNA Helicases | 1 | 2002 | 853 | 0.030 |
Why?
|
Dogs | 1 | 2022 | 3846 | 0.030 |
Why?
|
Disease Management | 2 | 2019 | 2536 | 0.030 |
Why?
|
Mice, Knockout | 2 | 2009 | 14481 | 0.030 |
Why?
|
Age Factors | 3 | 2020 | 18472 | 0.030 |
Why?
|
Ikaros Transcription Factor | 1 | 2018 | 233 | 0.030 |
Why?
|
Structure Collapse | 1 | 2016 | 4 | 0.030 |
Why?
|
Mice, Transgenic | 2 | 2021 | 9563 | 0.030 |
Why?
|
Aspirin | 1 | 2008 | 3136 | 0.030 |
Why?
|
Leukocyte Count | 1 | 2020 | 1605 | 0.030 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2008 | 2763 | 0.030 |
Why?
|
Genes, myc | 1 | 2017 | 391 | 0.030 |
Why?
|
STAT6 Transcription Factor | 1 | 2016 | 196 | 0.030 |
Why?
|
Germ Cells | 1 | 2020 | 643 | 0.030 |
Why?
|
Receptors, Fc | 1 | 2019 | 538 | 0.030 |
Why?
|
Lung | 1 | 2014 | 10087 | 0.030 |
Why?
|
Leukemia, Experimental | 1 | 2016 | 225 | 0.030 |
Why?
|
Dacarbazine | 1 | 2018 | 560 | 0.030 |
Why?
|
Bone Marrow Cells | 1 | 2023 | 2414 | 0.030 |
Why?
|
Heterozygote | 1 | 2002 | 2792 | 0.030 |
Why?
|
Gender Identity | 1 | 2021 | 770 | 0.030 |
Why?
|
Models, Genetic | 2 | 2002 | 3442 | 0.030 |
Why?
|
Antigens, CD34 | 1 | 2017 | 656 | 0.030 |
Why?
|
Doxorubicin | 1 | 2022 | 2229 | 0.030 |
Why?
|
STAT Transcription Factors | 1 | 2016 | 189 | 0.030 |
Why?
|
Cell Shape | 1 | 2016 | 371 | 0.030 |
Why?
|
Head | 1 | 2021 | 927 | 0.030 |
Why?
|
Blotting, Western | 1 | 2002 | 5033 | 0.030 |
Why?
|
Africa South of the Sahara | 1 | 2017 | 751 | 0.030 |
Why?
|
Janus Kinase 2 | 1 | 2018 | 561 | 0.030 |
Why?
|
Leiomyosarcoma | 1 | 2019 | 425 | 0.030 |
Why?
|
STAT1 Transcription Factor | 1 | 2016 | 343 | 0.030 |
Why?
|
Protein Binding | 2 | 2018 | 9346 | 0.030 |
Why?
|
Janus Kinases | 1 | 2016 | 253 | 0.030 |
Why?
|
Workflow | 1 | 2019 | 859 | 0.030 |
Why?
|
Follow-Up Studies | 2 | 2015 | 39405 | 0.030 |
Why?
|
Immune Evasion | 1 | 2018 | 376 | 0.030 |
Why?
|
T-Box Domain Proteins | 1 | 2017 | 473 | 0.030 |
Why?
|
Isoquinolines | 1 | 2016 | 354 | 0.030 |
Why?
|
Apoptosis | 2 | 2021 | 9506 | 0.030 |
Why?
|
Pericardial Effusion | 1 | 2016 | 246 | 0.030 |
Why?
|
Frameshift Mutation | 1 | 2016 | 393 | 0.030 |
Why?
|
Hepatitis, Autoimmune | 1 | 2016 | 173 | 0.030 |
Why?
|
Plasma Cells | 1 | 2017 | 599 | 0.030 |
Why?
|
Genes, p53 | 1 | 2016 | 715 | 0.030 |
Why?
|
Bone Density | 1 | 2006 | 3559 | 0.030 |
Why?
|
Age of Onset | 1 | 2020 | 3345 | 0.030 |
Why?
|
Genital Neoplasms, Female | 1 | 2019 | 538 | 0.030 |
Why?
|
Immunoglobulin Heavy Chains | 1 | 2016 | 648 | 0.030 |
Why?
|
Hepatitis B Core Antigens | 1 | 2013 | 90 | 0.030 |
Why?
|
RNA, Viral | 1 | 2021 | 2866 | 0.030 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2018 | 1339 | 0.030 |
Why?
|
Osteosarcoma | 1 | 2019 | 911 | 0.030 |
Why?
|
Neoplasm, Residual | 1 | 2018 | 1019 | 0.030 |
Why?
|
Gastrointestinal Tract | 1 | 2019 | 839 | 0.030 |
Why?
|
Antigen Presentation | 1 | 2018 | 1251 | 0.030 |
Why?
|
Daunorubicin | 1 | 2012 | 157 | 0.030 |
Why?
|
Gene Rearrangement, B-Lymphocyte, Heavy Chain | 1 | 2012 | 91 | 0.020 |
Why?
|
Ilium | 1 | 2012 | 155 | 0.020 |
Why?
|
Neural Conduction | 1 | 2013 | 443 | 0.020 |
Why?
|
Polyploidy | 1 | 2012 | 120 | 0.020 |
Why?
|
Sternum | 1 | 2012 | 177 | 0.020 |
Why?
|
Diagnostic Imaging | 2 | 2021 | 3541 | 0.020 |
Why?
|
Transplantation, Autologous | 1 | 2017 | 2127 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2017 | 997 | 0.020 |
Why?
|
Fatal Outcome | 1 | 2016 | 1837 | 0.020 |
Why?
|
Cell Proliferation | 2 | 2017 | 10464 | 0.020 |
Why?
|
Transplantation, Homologous | 1 | 2019 | 4834 | 0.020 |
Why?
|
Cytarabine | 1 | 2012 | 697 | 0.020 |
Why?
|
Diagnostic Errors | 1 | 2018 | 1280 | 0.020 |
Why?
|
North America | 1 | 2014 | 1290 | 0.020 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2015 | 1794 | 0.020 |
Why?
|
Muscle Weakness | 1 | 2013 | 415 | 0.020 |
Why?
|
Mice, Inbred C57BL | 2 | 2021 | 22355 | 0.020 |
Why?
|
Protein Kinase Inhibitors | 2 | 2017 | 5707 | 0.020 |
Why?
|
Signal Transduction | 3 | 2018 | 23629 | 0.020 |
Why?
|
NF-kappa B | 1 | 2018 | 2487 | 0.020 |
Why?
|
Infant | 3 | 2017 | 36512 | 0.020 |
Why?
|
Cohort Studies | 2 | 2023 | 41791 | 0.020 |
Why?
|
Chromatin | 1 | 2021 | 2967 | 0.020 |
Why?
|
Gene Rearrangement | 1 | 2014 | 1139 | 0.020 |
Why?
|
Risk Factors | 3 | 2020 | 74954 | 0.020 |
Why?
|
Chemokines, CXC | 1 | 2010 | 420 | 0.020 |
Why?
|
Gene Expression Profiling | 2 | 2016 | 9508 | 0.020 |
Why?
|
Bone Marrow Transplantation | 1 | 2016 | 2709 | 0.020 |
Why?
|
DNA | 1 | 2001 | 7211 | 0.020 |
Why?
|
Central Nervous System | 1 | 2015 | 1346 | 0.020 |
Why?
|
DNA Copy Number Variations | 1 | 2016 | 2046 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 2018 | 5496 | 0.020 |
Why?
|
Kinetics | 2 | 2007 | 6334 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2015 | 3553 | 0.020 |
Why?
|
Missouri | 1 | 2006 | 113 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2019 | 10776 | 0.020 |
Why?
|
Cell Survival | 1 | 2016 | 5792 | 0.020 |
Why?
|
United States | 1 | 2014 | 73144 | 0.020 |
Why?
|
Financial Support | 1 | 2006 | 116 | 0.020 |
Why?
|
Proteome | 1 | 2016 | 1880 | 0.020 |
Why?
|
Benzylamines | 1 | 2006 | 251 | 0.020 |
Why?
|
Heterocyclic Compounds | 1 | 2006 | 245 | 0.020 |
Why?
|
Fever | 1 | 2013 | 1620 | 0.020 |
Why?
|
ROC Curve | 1 | 2013 | 3622 | 0.020 |
Why?
|
Piperazines | 1 | 2016 | 2552 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2015 | 6856 | 0.020 |
Why?
|
Developing Countries | 1 | 2017 | 2903 | 0.020 |
Why?
|
Platelet Aggregation | 1 | 2008 | 769 | 0.020 |
Why?
|
Budgets | 1 | 2006 | 232 | 0.020 |
Why?
|
Melanoma, Experimental | 1 | 2008 | 559 | 0.020 |
Why?
|
Base Sequence | 1 | 2016 | 12421 | 0.010 |
Why?
|
Molecular Targeted Therapy | 1 | 2016 | 2830 | 0.010 |
Why?
|
Gene Expression | 1 | 2017 | 7595 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2019 | 12557 | 0.010 |
Why?
|
Coronary Artery Bypass | 1 | 2013 | 2194 | 0.010 |
Why?
|
Internet | 1 | 2016 | 3107 | 0.010 |
Why?
|
Time Factors | 2 | 2021 | 40267 | 0.010 |
Why?
|
Disease Progression | 1 | 2020 | 13646 | 0.010 |
Why?
|
Tumor Microenvironment | 1 | 2016 | 3940 | 0.010 |
Why?
|
Diphosphonates | 1 | 2007 | 635 | 0.010 |
Why?
|
Prostatic Neoplasms | 2 | 2019 | 11220 | 0.010 |
Why?
|
Flap Endonucleases | 1 | 2001 | 17 | 0.010 |
Why?
|
Rad52 DNA Repair and Recombination Protein | 1 | 2001 | 27 | 0.010 |
Why?
|
Cell Line | 1 | 2016 | 15593 | 0.010 |
Why?
|
Suppression, Genetic | 1 | 2001 | 190 | 0.010 |
Why?
|
Neoplasms, Experimental | 1 | 2006 | 1232 | 0.010 |
Why?
|
Neutropenia | 1 | 2006 | 893 | 0.010 |
Why?
|
Imidazoles | 1 | 2007 | 1168 | 0.010 |
Why?
|
Universities | 1 | 2006 | 1005 | 0.010 |
Why?
|
Head and Neck Neoplasms | 1 | 2015 | 2923 | 0.010 |
Why?
|
Liver | 1 | 2016 | 7570 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2018 | 15939 | 0.010 |
Why?
|
Research Design | 1 | 2016 | 6209 | 0.010 |
Why?
|
Bone Density Conservation Agents | 1 | 2007 | 797 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2019 | 16027 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2015 | 19019 | 0.010 |
Why?
|
Teaching | 1 | 2006 | 1172 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2016 | 10377 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2017 | 20224 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2015 | 6670 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2013 | 14736 | 0.010 |
Why?
|
Pain | 1 | 2013 | 5102 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2006 | 6228 | 0.010 |
Why?
|
Incidence | 1 | 2015 | 21544 | 0.010 |
Why?
|
Telomere | 1 | 2001 | 943 | 0.010 |
Why?
|
Cell Movement | 1 | 2006 | 5214 | 0.010 |
Why?
|
Neutrophils | 1 | 2006 | 3785 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2013 | 26410 | 0.010 |
Why?
|
Biomedical Research | 1 | 2006 | 3464 | 0.010 |
Why?
|
Anti-HIV Agents | 1 | 2006 | 4571 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2006 | 8051 | 0.010 |
Why?
|